Refining TIL Therapy through Selective Expansion & Genetic Engineering

Time: 2:30 pm
day: Conference Day Two PM

Details:

  • Isolating tumor-reactive TIL using phenotypic markers to enhance therapeutic specificity
  • Engineering selected TIL with viral constructs to boost potency and persistence
  • Expanding enriched TIL populations in optimized culture conditions to improve product quality

Speakers: